IMPACT BIOMEDICAL INC. (IBO)
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Impact BioMedical Inc.
NYSE:IBOHealthcare · Biotechnology
-4.83%$3.55
AH Close$3.55+0.00%vs close
AH$3.55+0.00%vs close
Mkt Cap$30.33M
Float938K
O/S8.54M
Inst Own3.6%
SI2.8%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$32K
Net Income-$11.84M
Total Assets$17.41M
Free Cash Flow-$1.89M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$12.61M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:12.62
Nasdaq bars a compliance period at 1:250
- 1:12.6Reverse splitSep 23, 202612.6 shares → 1
Balance Sheet Details
Assets$17.41M
Liabilities$1.85M
Accounts Receivable$203K
Accounts Payable$347K
Inventory$63K
PP&E (Net)$0
Goodwill$0
Intangible Assets$16.99M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | $32K | $0 | $0 | $50K | $50K | $0 |
| YoY Growth | - | - | - | 0.0% | - | - |
| Cost of Revenue | $424K | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | -$392K | $0 | $0 | $50K | $50K | $0 |
| Gross Margin | -1225.0% | - | - | 100.0% | 100.0% | - |
| Research and Development | $340K | $278K | $1.69M | $1.23M | $1.23M | $514K |
| Selling, General, and Administrative | $1.98M | $1.83M | $1.1M | $1.05M | $1.05M | $383K |
| Other | $1.56M | $26.65M | $1.24M | $1.18M | $1.18M | $0 |
| Total Operating Expenses | $3.88M | $28.75M | $4.03M | $3.45M | $3.45M | $897K |
| Operating Income (EBIT) | -$4.27M | -$28.75M | -$4.03M | -$3.4M | -$3.4M | -$897K |
| Operating Margin | -13343.8% | - | - | -6808.0% | -6808.0% | - |
| Interest Expense | $793K | $117K | $444K | $462K | $300K | $0 |
| Interest Income | $13K | $4K | $13K | $24K | $165K | $0 |
| Other Income (Expense) | -$10.18M | $4.02M | -$379K | -$4.47M | -$4.47M | $0 |
| Income Before Tax (EBT) | -$14.45M | -$24.74M | -$4.41M | -$7.88M | -$7.88M | -$897K |
| Income Tax Expense | -$2.58M | $33K | $0 | -$621K | -$621K | -$82K |
| Net Income | -$11.84M | -$24.71M | -$4.34M | -$7.05M | -$7.05M | -$597K |
| Net Income Margin | -36993.8% | - | - | -14102.0% | -14102.0% | - |
| Supplementary Data | ||||||
| EPS | -4.80 | -0.09 | -0.88 | -7.70 | -7.70 | -0.65 |
| Diluted EPS | -4.80 | -0.09 | -0.88 | -7.70 | -7.70 | -0.65 |
| Weighted Average OS | 2.50M | 3.31M | 4.77M | 911,070 | 911,070 | 911,565 |
| EBITDA | -$12.51M | -$22.55M | -$2.84M | -$6.3M | -$6.3M | -$897K |
| EBITDA Margin | -39100.0% | - | - | -12602.0% | -12602.0% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $3K | $2M | $1K | $2K | $46K | $72K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $3K | $2M | $1K | $2K | $46K | $72K |
| Accounts Receivable | $203K | $184K | $331K | $16K | $197K | $0 |
| Inventory | $63K | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $43K | $1K | $35K |
| Total Current Assets | $411K | $2.45M | $332K | $122K | $287K | $107K |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $0 | $17K | $287K | $276K | $0 | $0 |
| Goodwill | $0 | $0 | $25.09M | $25.09M | $25.09M | $25.09M |
| Intangible Assets | $16.99M | $17.81M | $18.92M | $20.03M | $21.15M | $22.26M |
| Long-Term Investments | $0 | $0 | $0 | $782K | $4.82M | $632K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $17K | $0 | $190K | $5.08M | $0 |
| Total Long-Term Assets | $16.99M | $17.84M | $44.3M | $46.38M | $56.14M | $47.99M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $17.41M | $20.29M | $44.63M | $46.5M | $56.42M | $48.09M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $347K | $314K | $832K | $539K | $115K | $9K |
| Short-Term Debt | $0 | $8.88M | $12.07M | $9.99M | $12.52M | $1.06M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $0 | $269 |
| Total Current Liabilities | $1.16M | $9.79M | $13.14M | $10.59M | $12.64M | $1.07M |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $688K | $3.27M | $3.23M | $3.23M | $3.86M | $5.25M |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $688K | $3.27M | $3.23M | $3.23M | $3.86M | $5.25M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.85M | $13.05M | $16.37M | $13.83M | $16.5M | $6.32M |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $60K | $60K | $0 | $0 | $0 |
| Common Stock | $105K | $11K | $10K | $70K | $125K | $125K |
| Retained Earnings | -$49.51M | -$37.67M | -$12.96M | -$8.63M | -$1.57M | -$271K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $62.01M | $41.92M | $38.17M | $38.11M | $38.06M | $38.06M |
| Total Equity | $12.61M | $4.26M | $25.22M | $29.56M | $36.61M | $37.91M |
| Minority Interest | $2.95M | $2.98M | $3.04M | $3.11M | $3.31M | $3.86M |
| Total Liabilities and Equity | $14.46M | $17.31M | $41.59M | $43.39M | $53.11M | $44.23M |
| Supplementary Data | ||||||
| Total Debt | $0 | $8.88M | $12.07M | $9.99M | $12.52M | $1.06M |
| Net Debt | -$3K | $6.88M | $12.07M | $9.99M | $12.48M | $987K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Operating Activities | ||||||
| Net Income | -$11.87M | -$35.53M | -$4.41M | -$7.25M | -$7.25M | -$597K |
| Depreciation & Amortization | $1.15M | $1.12M | $1.12M | $1.11M | $1.11M | $0 |
| Deferred Income Tax | -$2.58M | $47K | $0 | -$621K | -$621K | -$82K |
| Stock-Based Compensation | $13K | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | -$1K | $184K | -$128K | $0 | $0 | $0 |
| Inventory | $7K | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $470K | -$627K | $293K | $424K | $424K | $2K |
| Other Working Capital | $124K | -$431K | $271K | -$3K | -$3K | -$4K |
| Total Working Capital Change | $600K | -$874K | $436K | $421K | $421K | -$2K |
| Other Non-Cash Items | $10.8M | $29.6M | $0 | $4.1M | $4.1M | -$217K |
| Net Cash from Operating | -$1.89M | -$5.64M | -$2.85M | -$2.24M | -$2.24M | -$899K |
| Investing Activities | ||||||
| Capital Expenditures | $0 | $0 | -$18K | -$276K | -$276K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | -$65K | -$65K | -$632K |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $3K | $3K | $3K | -$8K | -$8K | $0 |
| Net Cash from Investing | $3K | $3K | -$15K | -$349K | -$349K | -$632K |
| Financing Activities | ||||||
| Debt Repaid | $109K | -$3.15M | - | - | - | -$1.06M |
| Common Stock Issuance | $0 | $5.36M | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | $435K |
| Net Cash from Financing | -$109K | $8.51M | $2.87M | $2.55M | $2.55M | $1.49M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $109K |
| Net Change in Cash | -$2M | $2.87M | -$1K | -$44K | -$44K | $72K |
| Supplementary Data | ||||||
| Operating Cash Flow | -$1.89M | -$5.64M | -$2.85M | -$2.24M | -$2.24M | -$899K |
| Capital Expenditure | $0 | $0 | -$18K | -$276K | -$276K | $3 |
| Free Cash Flow | -$1.89M | -$5.64M | -$2.87M | -$2.52M | -$2.52M | -$899K |
| Cash at Beginning | $2M | $1K | $2K | $46K | $46K | $0 |
| Cash at End | $3K | $2.87M | $1K | $2K | $2K | $72K |